Primary immunodeficiencies

Mayo Clinic Proceedings

Volumn 73, Issue 9, 1998, Pages 865-872

  Ten, Rosa M ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENZYME; IMMUNOGLOBULIN; LYMPHOKINE;

BONE MARROW TRANSPLANTATION; CELLULAR IMMUNODEFICIENCY; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; DNA REPAIR; GENE THERAPY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; REVIEW;

EID: 0031717009     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.9.865     Document Type: Review

References (40)

1. Azcona C, Alzina V, Barona P, Sierrasesûmaga L, Villa-Elïzaga I. Use of recombinant human granulocyte-macrophage colony simulating factor in an infant with reticular dysgenesis. EurJPediatr 1994:153:164166
2. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B cell-negative SCID. Science 1996;274:9799
3. DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Rscher A, de Saint Basile G. Defective human interleukin 2 receptor y chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sei USA 1994;91:9466-9470
4. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995;270:797-800
5. Hirschhorn R. Adenosine deaminase deficiency. Immunodefic Rev 1990:2:175-198
6. Markert ML. Purine nucleoside phosphorylase deficiency. Immunodefic Rev 1991;3:45-81
7. Le Deist F, Fischer A, Durandy A, Arnaud-Battandier F, Nezelof C, Hamet M, et al. Déficit immunitaire mixte et grave avec hyperéosinophilie: étude immunologique de cinq observations. Arch FrPediatr 1985;42:11-16
8. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 1995;16:539-546
9. Donato L, de la Salle H, Hanau D, Tongio MM, Oswald M, Vandevenne A, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr 1995:127:895-900
10. Alarcon B, Regueiro JR, Arnaiz-Villena A, Terhorst C. Familial defect in the surface expression of the T-cell receptor-CD3 complex. N Engl J Med 1988:319:1203-1208
11. Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 1994;76:947-958
12. Le Deist F, Hivroz C, Partiseti M, Thomas C, Buc HA, Oleastro M, et al. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 1995:85:1053-1062
13. Castigli E, Pahwa R, Good RA, Geha RS, Chatila TA. Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency. Proc Nail Acad Sei USA 1993;90:4728-4732
14. Rasio D, Negrini M, Croce CM. Genomic organization of the ATM locus involved in ataxia-telangiectasia. Cancer Res 1995;55:60536057
15. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995;83:655-666
16. Saar K, Chrzanowska KH, Stumm M, Jung M, Nürnberg G, Wienker TF, et al. The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21. Am J Hum Genêt 1997;60:605-610
17. Dupuy JM, Lafforet D. A defect of cellular immunity in Xeroderma pigmentosum. Clin Immunol Immunopathol 1974;3:52-58
18. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-644
19. Demczuk S, Aurias A. DiGeorge syndrome and related syndromes associated with 22qll.2 deletions: a review. Ann Genet 1995:38:59-76
20. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-lgM. Nature 1993;361:541-543
21. Rawlings DJ, Witte ON. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol Rev 1994;138:105-119
22. Cunningham-Rundles C. Clinical and immunologie analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33
23. Strober W, Sneller MC. IgA deficiency. Ann Allergy 1991:66:363-375
24. Morell A. Clinical relevance of IgG subclass deficiencies. Ann Biol Clin (Paris) 1994;52:49-52
25. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 1987:316:790-793
26. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the a subunit of the interleukin-4 receptor. N Engl J Med 1997:337:1720-1725
27. Schuster V, Seidenspinner S, Grimm T, Kress W, Zielen S, Bock M, et al. Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease. Eur J Pediatr 1994; 153:432-437
28. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995:268:1347-1349
29. Etzioni A. Adhesion molecule deficiencies and their clinical significance. Cell Adhes Commun 1994;2:257-260
30. Barrât FJ, Auloge L, Pastural E, Lagelouse RD, Vilmer E, Cant AJ, et al. Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome lq42-43. Am J Hum Genet 1996;59:625-632
31. Seger RA, Ezekowitz RA. Treatment of chronic granulomatous disease. Immunodeficiency 1994:5:113-130
32. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996;17:532-540
33. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J-F, Newport M, et al. Interferon-y-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-1961
34. Gölten HR, Rosen FS. Complement deficiencies. Annu Rev Immunol 1992:10:809-834
35. Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, et al. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 1987:316:589-596
36. Kohn DB, Weinberg Kl, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1:1017-1023
37. Müllen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood 1993:82:2961-2966
38. Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995:85:3328-3333
39. Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994:83:1149-1154
40. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De SaintBasile G, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993;123:564-572